关注
Hongyuan Cao
Hongyuan Cao
Associate Professor of Statistics at Florida State University
在 fsu.edu 的电子邮件经过验证 - 首页
标题
引用次数
年份
A powerful approach to identify replicable variants in genome-wide association studies
Y Li, H Lei, X Wen, H Cao
The American Journal of Human Genetics 111 (5), 966-978, 2024
2024
A powerful empirical Bayes approach for high dimensional replicability analysis
H Lei, Y Li, H Cao
arXiv preprint arXiv:2310.09701, 2023
2023
A powerful replicability analysis of genome-wide association studies
Y Li, H Lei, X Wen, H Cao
medRxiv, 2023.09. 04.23295018, 2023
2023
A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up
RH Grogan, SP Kaplan, H Cao, RE Weiss, LJ DeGroot, CA Simon, ...
Surgery 154 (6), 1436-1447, 2013
2962013
Analysis of asynchronous longitudinal data with partially linear models
L Chen, H Cao
Electronic Journal of Statistics 11 (1), 1549-1569, 2017
152017
Analysis of the proportional hazards model with sparse longitudinal covariates
H Cao, MM Churpek, D Zeng, JP Fine
Journal of the American Statistical Association 110 (511), 1187-1196, 2015
322015
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancer
MT Spiotto, H Cao, L Mell, FG Toback
Anti-cancer drugs 26 (3), 343-349, 2015
82015
Array Platform Modeling and Analysis (A)
LX Qin, S Ma, YT Huang, H Zhang, H Cao
Cancer Informatics 13, CIN. S22973, 2014
2014
Assessing agreement with multiple raters on correlated kappa statistics
H Cao, PK Sen, AF Peery, ES Dellon
Biometrical Journal 58 (4), 935-943, 2016
272016
Assessing non-inferiority for incomplete paired-data under non-ignorable missing mechanism
H Li, G Tian, N Tang, H Cao
Computational statistics & data analysis 127, 69-81, 2018
12018
Background: Several (neo) adjuvant treatments for patients with HER2-positive breast cancer have been compared in different randomized clinical trials. Since it is not feasible …
M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ...
Frontiers in Oncology 8 (156), 1, 2018
2018
Changepoint estimation: another look at multiple testing problems
H Cao, W Biao Wu
Biometrika 102 (4), 974-980, 2015
312015
Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization
S Becker-Dreps, M Paniagua, R Dominik, H Cao, NK Shah, DR Morgan, ...
The Pediatric infectious disease journal 30 (3), 243-247, 2011
322011
Clinical evaluation of cisplatin sensitivity germ line polymorphisms in neoadjuvant chemotherapy (NAC) for urothelial cancer (UC).
PH O'Donnell, IR Garcia-Grossman, H Cao, I Ostrovnaya, ER Plimack, ...
Journal of Clinical Oncology 32 (4_suppl), 342-342, 2014
2014
Clinical evaluation of cisplatin sensitivity of germline polymorphisms in neoadjuvant chemotherapy for urothelial cancer
PH O’Donnell, S Alanee, KL Stratton, IR Garcia-Grossman, H Cao, ...
Clinical genitourinary cancer 14 (6), 511-517, 2016
82016
Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant
CR Petri, PH O’Donnell, H Cao, AS Artz, W Stock, A Wickrema, M Hard, ...
Leukemia & lymphoma 55 (12), 2866-2873, 2014
182014
Combining protein sequences and structures with transformers and equivariant graph neural networks to predict protein function
JC Frimpong Boadu, Hongyuan Cao
Bioinformatics 39, i318-i325, 2023
172023
Combining protein sequences and structures with transformers and equivariant graph neural networks to predict protein function
JC Frimpong Boadu, Hongyuan Cao
Bioinformatics, 0
Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis
M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ...
Frontiers in Oncology 8, 156, 2018
362018
Evaluating two PTI test procedures for control of delivered dose uniformity for aerosol products
Y Lan, CT Lin, H Cao
Statistics in Biopharmaceutical Research 4 (2), 136-148, 2012
12012
系统目前无法执行此操作,请稍后再试。
文章 1–20